Application 202472
- Type
- ANDA
- Sponsor
- ACTAVIS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZOLEDRONIC ACID | ZOLEDRONIC ACID | INJECTABLE;INTRAVENOUS | EQ 4MG BASE/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202472-001 | ZOLEDRONIC ACID | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | AP | 2013-03-04 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A202472-001 | ZOLEDRONIC ACID | EQ 4MG BASE/5ML | INJECTABLE / INTRAVENOUS | 2013-03-04 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-07-19 19:46 UTC | 2019-07 | A202472-001 | AP | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zoledronic Acid | ZOLEDRONIC ACID | Meitheal Pharmaceuticals Inc. | 8aac81ae-f92c-4f0b-b480-44badf72b5f5 | 2026-07-09 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Eugia US LLC | bf5f96d4-f87c-4968-bed0-a4b5e77f4162 | 2026-05-15 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Mylan Institutional LLC | 80006f10-85a3-4390-b5dc-3b2097134f3d | 2026-03-18 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Mylan Institutional LLC | 1977d713-4cc7-405e-b4c1-a9a91635eff6 | 2026-03-16 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic acid | ZOLEDRONIC ACID | Gland Pharma Limited | d761011b-edd6-4d3f-bacd-8607dc2414fc | 2026-02-27 | Warnings, Adverse reactions | Zoledronic acid ZOLEDRONIC ACID |
| Zoledronic acid | ZOLEDRONIC ACID | FOSUN PHARMA USA INC | fd0324d8-b9bd-fd4c-e053-6394a90a5465 | 2026-02-26 | Warnings, Adverse reactions | Zoledronic acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Gland Pharma Limited | 824eaeee-6b3d-4d62-b268-77f8bd8e7f10 | 2026-02-24 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| zoledronic acid | ZOLEDRONIC ACID | Gland Pharma Limited | 46c3a880-3723-45cf-979e-57ef6391662e | 2026-02-06 | Warnings, Adverse reactions | zoledronic acid ZOLEDRONIC ACID |
| Reclast | ZOLEDRONIC ACID | Sandoz Inc | 5a9b3737-9ce6-4a89-b76e-6aab79eba9cf | 2026-02-03 | Warnings, Adverse reactions | ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | BPI Labs LLC | 1b556f75-9174-4798-8c8d-21cf34beac13 | 2025-12-26 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic acid | ZOLEDRONIC ACID | Accord Healthcare Inc. | 3df715a1-2562-4374-a383-6edc33c6e52f | 2025-10-08 | Warnings, Adverse reactions | Zoledronic acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | BPI Labs LLC | 634e9d4b-e940-4743-ad39-794dad28d79b | 2025-10-03 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic acid | ZOLEDRONIC ACID | BluePoint Laboratories | f433c13c-dd8c-4dca-834e-a4ecf09d1eab | 2025-09-03 | Warnings, Adverse reactions | Zoledronic acid ZOLEDRONIC ACID |
| zoledronic acid | ZOLEDRONIC ACID | Sagent Pharmaceuticals | 567578e6-cd2d-4339-b0f6-7a15444c0639 | 2025-03-11 | Warnings, Adverse reactions | zoledronic acid ZOLEDRONIC ACID |
| zoledronic acid | ZOLEDRONIC ACID | Sagent Pharmaceuticals | 164500d7-51cf-438a-8bee-7a7dce76ad7a | 2025-03-11 | Warnings, Adverse reactions | zoledronic acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Avenacy Inc. | 4b699dd8-d232-4bdb-88ce-9b42ed93e036 | 2025-01-15 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Gland Pharma Limited | 7a5e8962-7c4b-40bb-ad69-0c3edb0338af | 2023-11-15 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Dr. Reddy's Laboratories Inc. | bbb29627-76b5-e742-0e79-ef3bf22021b8 | 2023-10-30 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Dr. Reddy's Laboratories Inc. | 72623e70-9db3-f1b8-de7d-c1a61d71fb01 | 2023-10-30 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Dr. Reddy's Laboratories Limited | 1738a682-5903-b675-3a7a-61d299a6f248 | 2023-10-30 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.